Endometrial cancer (EC) is one of the most common gynaecological malignancies in high-income countries and is associated with ...

Hogan Lovells’ Ben Kostrzewa says U.S.-China trade ties are unlikely to fully decouple, but persistent frictions will force ...

MLC Anil Parab on Sunday alleged large-scale rigging and cartelisation in the Rs 90 crore Vikhroli FoB tender. Parab also ...

Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The findings provide a clearer understanding of how these tumors develop, ...

Add Yahoo as a preferred source to see more of our stories on Google. DANIEL TUKEY, 39, was fly-fishing about a mile off Cape Cod about three years ago when his phone rang. It was Memorial Sloan ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery, and radiation for some forms of cancer. Nearly 80% of patients who suffered from a ...

Dostarlimab offers hope in cancer treatment. Study shows tumour shrinkage in patients with mismatch repair defect. Some ...

Results from a groundbreaking clinical trial could soon change the way certain types of cancers are treated. A study published Sunday in the New England Journal of Medicine found that immunotherapy ...

—In this study, molecular classification of endometrial cancer with cervical stromal invasion was associated with recurrence-free survival by univariate analysis. But after controlling for tumor stage ...

New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study, it was found ...

A study at Radboud university medical center shows that immunotherapy effectively slows prostate cancer progression by 33 months in men with specific genetic mutations. Targeted subtypes MMRd, hTMB, ...